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Carnosine, a histidine-containing dipeptide, is well known to be associated with skel-
etal muscle performance. However, there is limited information on the effect of dietary 
micronutrients on muscle carnosine level. Pyridoxal 5′-phosphate (PLP), the active form 
of vitamin B6, is involved in amino acid metabolisms in the body as a cofactor. We 
hypothesized that enzymes involved in β-alanine biosynthesis, the rate-limiting precursor 
of carnosine, may also be PLP dependent. Thus, we examined the effects of dietary 
vitamin B6 on the muscle carnosine content of rats. Male and female rats were fed a diet 
containing 1, 7, or 35 mg pyridoxine (PN) HCl/kg for 6 weeks. Carnosine in skeletal mus-
cles was quantified by ultra-performance liquid chromatography coupled with tandem 
mass spectrometry. In the gastrocnemius muscle of male rats, carnosine concentration 
was significantly higher in the 7 and 35 mg groups (+70 and +61%, respectively) than 
in the 1  mg PN HCl/kg group, whereas that in the soleus muscle of male rats was 
significantly higher only in the 7 mg group (+43%) than in the 1 mg PN HCl/kg group 
(P <  0.05). In both muscles of female rats, carnosine concentration was significantly 
higher in the 7 and 35 mg groups (+32 to +226%) than in the 1 mg PN HCl/kg group 
(P < 0.05). We also found that, compared to the 1 mg group, β-alanine concentrations 
in the 7 and 35 mg groups were markedly elevated in gastrocnemius muscles of male 
(+153 and +148%, respectively, P < 0.05) and female (+381 and +437%, respectively, 
P < 0.05) rats. Noteworthy, the concentrations of ornithine in the 7 and 35 mg groups 
were decreased in gastrocnemius muscles of male rats (−46 and −54%, respectively, 
P < 0.05), which strongly inversely correlated with β-alanine concentration (r = −0.84, 
P < 0.01). In humans, 19% lower muscle carnosine content was found in soleus muscle 
of women of the lower plasma PLP tertile, but this was not observed in gastrocnemius 
muscle or in men. We conclude that adequate dietary vitamin B6 is essential for main-
taining carnosine in skeletal muscles of rats. Significantly lower soleus carnosine content 
among women close to PLP deficiency suggests that a similar phenomenon exists in 
the humans.
Keywords: vitamin B6, carnosine, skeletal muscles, rats, human volunteers
Abbreviations: PLP, pyridoxal 5′-phosphate; PN, pyridoxine; UPLC-MS/MS, ultra-performance liquid chromatography 
coupled with tandem mass spectrometry.
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inTrODUcTiOn
Skeletal muscle contains at least 80% of the vitamin B6 pool in 
the body as pyridoxal 5′-phosphate (PLP) bound to glycogen 
phosphorylase. This information led to the studies on the effect 
of vitamin B6 status on exercise. A study by Richardson and 
Chenman suggested that vitamin B6 intake increased stamina as a 
result of prolonging muscle contraction (1). A case study demon-
strated that vitamin B6 supplementation is beneficial for McArdle 
disease, a glycogenetic myopathy, especially for alleviating fatigue 
(2). A clinical trial also showed that a combined restricted intake 
of thiamine, riboflavin, and vitamins B6 and C causes a decrease 
in physical performance in humans (3). However, another 
study suggested that vitamin B6 supplementation, far higher 
than minimum daily requirement, had no positive effect on the 
exercise performance of rats (4). On the other hand, plasma PLP 
concentration is reported to increase after exercise (5). Thus, the 
role of vitamin B6 in skeletal muscle still remains unclear.
Pyridoxal 5′-phosphate, the active form of vitamin B6, acts as a 
cofactor for several enzymes involved in amino acid metabolisms. 
Some reports indicate that vitamin B6 deficiency modulates free 
amino acids levels in blood and tissues (6–8). Some enzymes mod-
ulating β-alanine metabolism, the precursor of carnosine, are PLP 
dependent. Recently, we reported that insufficient dietary vitamin 
B6 lowers the concentrations of carnosine and anserine in the heart 
of rats (9). Carnosine (beta-alanyl-l-histidine) and its methyl-
ated analog anserine are abundant dipeptides in skeletal muscle. 
They constitute an integral part of skeletal muscle contractility 
and homeostasis, presumably through their role as anti-oxidant, 
pH-buffering, anti-glycation and/or calcium regulator (10, 11). 
We hypothesized that dietary vitamin B6 plays an important role 
in maintaining muscle carnosine and anserine. Accordingly, this 
study investigated the effects of a low or high vitamin B6 diet on 
the levels of these metabolites and the related metabolites, such as 
β-alanine and ornithine, in the skeletal muscles of rats. Here, we 
report evidence that insufficient vitamin B6 intake lowers concen-
tration of carnosine, which is a putative ergogenic factor, in the 
gastrocnemius and soleus muscles of male and female rats. In order 
to explore the relevance of our findings to humans, we additionally 
investigated the possible relationship between vitamin B6 status 




Male and female Sprague–Dawley rats (3  weeks old, Charles 
River Japan, Hino, Japan) were maintained in accordance with 
the Guide for the Care and Use of Laboratory Animals established 
by Hiroshima University. Rats were housed in metal cages in a 
temperature controlled room (24 ± 1°C) and a 12-h light/dark 
cycle (lights on, 0800–2000 h). Rats had free access to food and 
deionized water. Rats were fed a commercial non-purified diet 
(MF, Oriental Yeast, Tokyo, Japan) for 1 week. In experiment 1, 
24 male rats (average, 113 g) were divided randomly into three 
groups receiving 1, 7, or 35 mg Pyridoxine (PN) HCl/kg diet 
(n = 8/group) for 6 weeks. In experiment 2, 24 female rats were 
treated in the same way (average, 109 g). The basal diet com-
prised the components as described previously (12). PN HCl 
was supplemented to the basal diet at 1, 7, or 35 mg/kg diet. 
The level of PN HCl/kg diet recommended in the AIN-93 diet is 
7 mg/kg (13). Meanwhile, 1 mg PN HCl/kg diet is reported to be 
the minimum level required for preventing growth depression 
caused by vitamin B6 deficiency (14). The animals were sac-
rificed by decapitation under diethyl ether anesthesia. Serum 
was collected and stored at −60°C. Gastrocnemius and soleus 
muscles were quickly dissected, frozen in liquid nitrogen, and 
immediately stored at −80°C until analysis.
Analysis of PLP in Serum and Skeletal Muscles  
by HPLC
The experimental methods were done as describe before (12). 
Briefly, vitamin B6 from serum was extracted using 3 N perchlo-
ric acid. PLP was converted to pyridoxic acid 5′-phosphate and 
measured by HPLC with a fluorometric detector (15). Muscles 
supernatant of each two rats from the same group were combined 
to obtain pooled samples for the analysis (n = 4/group). PLP in 
the pooled samples was measured in the same method (15).
Analysis of Carnosine, Anserine, and β-Alanine in 
Skeletal Muscles by UPLC-MS/MS Method
The experimental methods were done as describe before (9). Briefly, 
gastrocnemius and soleus muscles were treated with cold 3% sulfo-
salicylic acid to precipitate the proteins. The supernatant liquid of 
each two rats from the same group were combined to obtain pooled 
samples for the analysis (n = 4/group). The samples from male and 
female rats are represented in experiments 1 and 2, respectively.
Analysis of Ornithine in Skeletal Muscles by an 
Amino Acid Analyzer
The same pooled samples for the ultra-performance liquid 
chromatography coupled with tandem mass spectrometry 
(UPLC-MS/MS) analysis were used for ornithine analysis (n = 4/
group). Ornithine concentration was quantified by an amino acid 
analyzer (JLC-500; JEOL, Tokyo, Japan). Amino acids mixture 
standard solutions (type AN-2 and type B) were used as standard 
solution (Wako, Osaka, Japan).
human study
Human data were obtained from 24 male (age 20.6 ±  0.12  years) 
and 58 female (age 24.0  ±  0.12  years) recreationally active and 
healthy individuals. The study protocols were approved by the local 
ethical committee (Ghent University Hospital, Belgium) and written 
informed consent was obtained from all participants prior to the study.
Muscle carnosine concentration was determined non-invasively 
by proton magnetic resonance spectroscopy (1H-MRS) by means 
of a 3-T whole-body MRI scanner (Siemens Trio, Erlangen, 
Germany) as described by Baguet et al.(16). Muscle carnosine was 
determined in the soleus and gastrocnemius muscle of the right leg.
Venous blood samples were collected from an antecubital vein 
in EDTA tubes, immediately centrifuged after which the plasma 
was immediately stored at −80°C before analysis. Pre-analytical 
TaBle 1 | Body weight, food intake, muscles weight, and muscles PlP.
Pn hcl/kg 1 mg 7 mg 35 mg
experiment 1 (male rats)
Initial body weight (g) 113 ± 2 113 ± 1 113 ± 2
Final body weight (g) 434 ± 23 452 ± 12 461 ± 12
Food intake (g/6 week) 738 ± 40 793 ± 29 768 ± 18
Gastrocnemius muscle weight (g) 2.57 ± 0.08 2.47 ± 0.06 2.58 ± 0.14
Gastrocnemius muscle PLP 
(nmol/g)
9.1 ± 0.7a 12.8 ± 0.6b 12.8 ± 0.8b
Soleus muscle weight (g) 0.18 ± 0.01 0.17 ± 0.01 0.19 ± 0.01
Soleus PLP (nmol/g) 2.7 ± 0.3a 4.8 ± 0.2b 5.3 ± 0.1b
experiment 2 (female rats)
Initial body weight (g) 108 ± 2 109 ± 2 109 ± 2
Final body weight (g) 253 ± 5a 276 ± 9a,b 288 ± 8b
Food intake (g/6 week) 583 ± 13 630 ± 18 638 ± 16
Gastrocnemius muscle weight (g) 1.58 ± 0.04 1.73 ± 0.06 1.75 ± 0.07
Gastrocnemius muscle PLP 
(nmol/g)
7.6 ± 0.8a 14.5 ± 1.4b 14.5 ± 0.6b
Soleus muscle weight (g) 0.11 ± 0.00 0.12 ± 0.01 0.13 ± 0.01
Soleus muscle PLP (nmol/g) 2.0 ± 0.1a 5.1 ± 0.4b 5.4 ± 0.2b
Mean ± SE (n = 7–8).
a,bMeans are significantly different by Tukey’s multiple-range test (P < 0.05).
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handling was performed in light-protected vials as described in 
the Chromsystem manual. PLP concentration was determined 
using a commercial HPLC-fluorescence method (52000/Premix, 
Chromsystems instruments & chemicals GmbH, Germany) (17). 
Non-fasted participants were in rest before and during the deter-
mination of muscle carnosine and at the time of blood withdrawal.
statistical analysis
Data are expressed as means ±  SE. Tukey’s multiple-range test 
was used to compare means after one-way ANOVA. Statistical 
significance of the difference among means was estimated at 
P < 0.05. Data analysis was performed using Excel Statistics 2010 
for Windows (Social Survey Research Information Co., Ltd., 
Tokyo, Japan). Some data underwent regression analysis and the 
correlation coefficient was calculated.
The relationship between human plasma PLP levels and muscle 
carnosine levels was analyzed separately for men and women, given the 
known sex difference in muscle carnosine (16). Within each sex, sub-
jects were divided into tertiles based on plasma PLP levels. Differences 
between tertiles were analyzed by ANOVA or Kruskal–Wallis depend-
ing on the results of the Levene test. Post hoc analyses were performed 
using Tukey or Wilcoxon tests. Relationships between some variables for 
both human and rodent studies were investigated by regression analysis 
and the Pearson coefficient determined (IBM Corp. Released 2013. IBM 
SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp).
resUlTs
animal study
Experiment 1 (Male Rats)
Food Intake, Body Weight, and Skeletal Muscles Weight of 
Male Rats
Dietary manipulation did not affect food intake, final body 
weight, and weight of skeletal muscles (P >  0.05 by ANOVA 
analysis, Table 1).
PLP Concentrations in Serum and Skeletal Muscles of Male 
Rats
Serum PLP concentration increased in dose-dependent manner 
by vitamin B6 supplementation (0.17 ±  10, 0.55 ±  0.03, and 
1.08 ± 0.07 μmol/L in the 1, 7, and 35 mg PN HCl/kg groups, 
P <  0.01 by ANOVA analysis). In gastrocnemius muscle, both 
the 7 and 35 mg groups showed +41% higher concentration of 
PLP (P < 0.05, Table 1) when compared to the 1 mg PN HCl/kg 
group. In soleus muscle, compared to the 1 mg PN HCl/kg group, 
the 7 and 35 mg groups had +81 and +100%, respectively higher 
concentration of PLP (P < 0.05, Table 1), without any differences 
between these groups (P > 0.05).
Concentrations of Carnosine, Anserine, β-Alanine, and 
Ornithine in Skeletal Muscles of Male Rats
In the gastrocnemius muscle, the 7 and 35  mg groups had 
higher concentrations of carnosine (+70 and +61%, respectively, 
P < 0.05, Figure 1A) than that in the 1 mg PN HCl/kg group. The 
concentration of anserine was also higher (+58%) in 35 mg group 
when compared to 1 mg PN HCl/kg group (P < 0.05, Figure 1B). 
Carnosine and anserine concentrations were strongly correlated 
(r = 0.80, P < 0.01). The concentration of β-alanine was markedly 
higher in the 7 and 35 mg groups than that in the 1 mg PN HCl/
kg group (+153 and +148%, respectively, P < 0.05, Figure 1C). 
There was a strong correlation between carnosine and β-alanine 
concentrations (r = 0.89, P < 0.01). Concentrations of carnosine, 
anserine, and β-alanine in the gastrocnemius muscle did not dif-
fer between the 7 and 35 mg PN HCl/kg groups.
Analysis using amino acid analyzer indicated that, in the gastroc-
nemius muscle, the concentration of ornithine was significantly lower 
in the 7 and 35 mg groups than the 1 mg PN HCl/kg group (−46 and 
−54%, respectively, P < 0.05, Figure 1D). Ornithine concentration 
was inversely correlated with β-alanine concentration (r = −0.84, 
P < 0.01).
In the soleus muscle, the 7 mg group had higher concentra-
tion of carnosine (+43%) than that in the 1 mg PN HCl/kg group 
(P < 0.05, Figure 1E), but the 35 mg group did not. There was no 
difference in the concentration of anserine among these groups 
(P > 0.05, Figure 1F). However, carnosine and anserine concen-
trations showed a significant correlation (r = 0.70, P < 0.05). The 
concentration of β-alanine did not differ between 1 and 35 mg 
groups (P > 0.05, Figure 1G), but lower in 35 mg group when 
compared to 7  mg group (−34%, P <  0.05, Figure  1G). There 
was no significant correlation between carnosine and β-alanine 
concentrations (r = 0.45, P > 0.05).
In the soleus muscle, the concentration of ornithine was signifi-
cantly lower in the 7 and 35 mg groups than the 1 mg PN HCl/kg 
group (−19 and −25%, respectively, P < 0.05, Figure 1H). There 
was no significant correlation between ornithine and β-alanine 
concentrations (r = 0.32, P > 0.05).
Experiment 2 (Female Rats)
Food Intake, Body Weight, and Skeletal Muscles Weight of 
Female Rats
Dietary manipulation did not affect food intake and skeletal muscles 
weight (P > 0.05 by ANOVA analysis, Table 1). Compared to the 1 mg 
FigUre 1 | effect of dietary vitamin B6 levels on the concentrations of carnosine, anserine, β-alanine, and ornithine in gastrocnemius and soleus 
muscles of male rats. Gastrocnemius muscle samples from male rats (n = 4) were analyzed for its concentrations of carnosine (a), anserine (B), β-alanine (c), 
and ornithine (D). Soleus muscle samples from male rats (n = 4) were analyzed for its concentrations of carnosine (e), anserine (F), β-alanine (g), and ornithine (h). 
Values are means ± SE. Groups with different letters are significantly different from each other, P < 0.05 (Tukey’s multiple-range test).
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group, 35 mg PN HCl/kg group showed slightly higher final body 
weight in female rats (P < 0.05 by Tukey’s multiple-range test, Table 1).
PLP Concentrations in Serum and Skeletal Muscles of Female 
Rats
Serum PLP concentration increased in dose-dependent man-
ner by vitamin B6 supplementation (0.05 ± 0.01, 0.45 ± 0.03, 
and 0.73 ±  0.07 μmol/L in the 1, 7, and 35  mg PN HCl/kg 
groups, P < 0.01 by ANOVA analysis). In gastrocnemius mus-
cle, both 7 and 35 mg groups showed +91% higher concentra-
tion of PLP (P < 0.05, Table 1) when compared to 1 mg PN 
HCl/kg group. In soleus muscle, compared to the 1 mg group, 
the 7 and 35 mg PN HCl/kg groups had higher concentration 
of PLP (+156 and +172%, respectively, P < 0.05, Table 1).
Concentrations of Carnosine, Anserine, β-Alanine, and 
Ornithine in Skeletal Muscles of Female Rats
In the gastrocnemius muscle, the 7 and 35 mg groups had mark-
edly higher concentrations of carnosine (+211 and +226%, 
respectively, P  <  0.001, Figure  2A) and anserine (+100 and 
+128%, respectively, P <  0.01, Figure  2B), than those in the 
1 mg PN HCl/kg group. Carnosine and anserine concentrations 
were strongly correlated (r = 0.89, P < 0.01). The concentration 
of β-alanine was remarkably higher in the 7 and 35 mg groups 
than that in the 1  mg PN HCl/kg group (+381 and +437%, 
respectively, P < 0.001, Figure 2C). There was a strong correla-
tion between carnosine and β-alanine concentrations (r = 0.96, 
P < 0.01). Concentrations of carnosine, anserine, and β-alanine 
in the gastrocnemius muscle did not differ between the 7 and 
35 mg PN HCl/kg groups.
In the gastrocnemius muscle, the concentration of ornithine 
tended to be lower in the 7 and 35 mg groups, −64 and −54% 
respectively, than the 1 mg PN HCl/kg group (P = 0.066 by ANOVA 
analysis, Figure 2D). Ornithine concentration was inversely cor-
related with β-alanine concentration (r = −0.65, P < 0.05).
In the soleus muscle, the 7 and 35 mg groups had significantly 
higher concentrations of carnosine (+156 and +172%, respec-
tively, P < 0.001, Figure 2E), when compared to the 1 mg PN HCl/
kg group. There were no significant differences in the concentra-
tions of anserine and β-alanine among the three groups (P > 0.05, 
Figures  2F,G). There was no significant correlation between 
carnosine and β-alanine concentrations (r = 0.56, P > 0.05).
In the soleus muscle, the concentration of ornithine tended to 
be lower in the 7 and 35 mg groups, −64 and −54% respectively, 
than the 1 mg PN HCl/kg group (P = 0.069 by ANOVA analysis, 
Figure 2H). There was no significant correlation between ornith-
ine and β-alanine concentrations (r = −0.01, P > 0.05).
Human Study (Experiment 3)
Concentrations of Plasma PLP and Muscle Carnosine in 
Humans
In the human cohort, plasma PLP concentrations ranged 
between 25.2 and 203.9 nmol/L in women, and between 52.2 and 
571.3 nmol/L in men. No individuals could be termed deficient 
FigUre 2 | effect of dietary vitamin B6 levels on the concentrations of carnosine, anserine, β-alanine, and ornithine in gastrocnemius and soleus 
muscles of female rats. Gastrocnemius muscle samples from female rats (n = 4) were analyzed for its concentrations of carnosine (a), anserine (B), β-alanine (c), 
and ornithine (D). Soleus muscle samples from female rats (n = 4) were analyzed for its concentrations of carnosine (e), anserine (F), β-alanine (g), and ornithine 
(h). Values are means ± SE. Groups with different letters are significantly different from each other, P < 0.05 (Tukey’s multiple-range test).
FigUre 3 | association of plasma PlP with carnosine concentrations 
in different tertiles of women (a) and men (B). Values are means ± SE. 
Groups with different letters are significantly different from each other, 
P < 0.05 (Tukey’s multiple-range test).
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(<20 nmol/L) and only one had insufficient (<30 nmol/L) plasma 
PLP (25.2 nmol/L). In the latter subject, the carnosine concentra-
tions in soleus and gastrocnemius muscle were, respectively, 2.72 
and 3.21 μmol/g tissue, which is −0.19 and −0.63 z-score below 
the average of our reference database containing 90 women.
The known difference in carnosine concentrations between 
men and women (18) was confirmed in this cohort (P <  0.05). 
Therefore, tertiles for PLP were calculated separately for both 
sexes. Carnosine concentrations were 19.5 (P < 0.05) and 18.8% 
(P < 0.05) lower in the lowest tertile of the soleus of women com-
pared to mid and high tertile (Figure 3A). No other differences 
(women gastrocnemius, or men soleus and gastrocnemius) were 
found (Figures 3A,B). In women, a positive correlation of r = 0.31 
and r = 0.29 was established between plasma PLP and, respectively, 
soleus and gastrocnemius muscles (P < 0.05 and P < 0.05). In men, 
a correlation in the soleus (r = 0.41, P < 0.05), but not in the gas-
trocnemius (r = 0.04, P > 0.05), muscle was found. The male cohort 
contained one outlier (plasma PLP = 570 nmol/L). After deletion of 
this outlier, no correlation was found in either muscle (respectively, 
for soleus and gastrocnemius r = −0.23 and −0.10; P > 0.05).
DiscUssiOn
This study demonstrated that dietary vitamin B6 supplementation 
(i.e., 7 and/or 35 mg PN HCl/kg) compared to a low-vitamin B6 diet 
(i.e., 1 mg PN HCl/kg) significantly increased the concentrations of 
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carnosine in the skeletal muscles of male and female rats. Meanwhile, 
dietary supplemental vitamin B6 appeared to affect the anserine 
concentrations to a lesser extent. An elevated muscle carnosine 
and anserine content exerts beneficial effects on the skeletal muscle 
contractility, as shown in isolated human muscle fibers (19), isolated 
rodent muscles (20), and in vivo human muscles (18). The underlying 
ergogenic mechanism probably relates to the dipeptides’ capacity as 
an anti-oxidant, pH-buffer, and/or calcium regulator (10, 21). Thus, 
the present results imply that maintaining recommended amounts of 
dietary vitamin B6 might be favorable for skeletal muscles function 
by elevating the histidyl-dipeptides, especially carnosine.
The present study shows that the dependency of carnosine 
concentration on dietary vitamin B6 intake was more remarkable in 
the gastrocnemius than the soleus muscle in both male and female 
rats. Oppositely, in humans, the link between vitamin B6 status and 
muscle carnosine was only found in (female) soleus, not gastroc-
nemius. The gastrocnemius muscle comprises a high proportion 
of type II myofibers, which are “fast-twitch” fibers; meanwhile, the 
soleus muscle comprises predominantly type I myofibers, which are 
characteristically “slow-twitch” fibers. On the other hand, compared 
to the male rats, the female rats appeared to show more remarkable 
increase in carnosine concentration by dietary B6 supplementation 
in gastrocnemius muscle. Thus, the effects of vitamin B6 status on 
carnosine concentrations in skeletal muscles appear to differ with 
respect to muscle fiber type, gender, species, and the interaction of 
these factors. However, the reason for this is unknown.
Dietary supplementation of carnosine and β-alanine is 
reported to increase carnosine concentration in the skeletal 
muscles (22, 23), whereas a histidine-deficient diet can reduce 
carnosine concentration (24). However, those studies involve 
chronic dietary intervention of high doses of carnosine and 
β-alanine, or severe histidine-deficiency conditions (22–24). 
By contrast, the present study used diets ranging from a low-
vitamin B6 diet (marginal vitamin B6-deficient diet) that did not 
induce severe vitamin B6 deficiency to somewhat higher vitamin 
B6 diets far below the supraphysiological dose (i.e., acute toxic 
dose). To our knowledge, this is the first evidence indicating 
dietary intake of a nutrient close to the range of regular daily 
intake plays a pivotal role in maintaining carnosine concentra-
tion in skeletal muscles.
In order to find out whether the rodent data could be repli-
cated in humans, we measured carnosine and PLP in volunteers. 
We divided the female and male participants separately into 
tertiles in order to try to mimic the three conditions in the rats. 
However, the lowest tertile was not as insufficient as the rats in 
the 1  mg PN HCl/kg group were. Still, we found that women 
have significantly reduced muscle carnosine content in the lowest 
PLP tertile compared to the higher tertiles. Moreover this was 
somewhat confirmed by the low, but significant correlation. In 
men, these results could not be replicated. This is probably due 
to the fact that the lowest tertile in men was not as close to the 
insufficient range as the women were. We can conclude from the 
human data in this study that to some extent a similar pattern 
could be recognized as in the rats, albeit only in women. Yet, 
it is expected that the vitamin B6 dependency would probably 
be more pronounced if the study group would have included 
truly vitamin B6-deficient humans. Obviously, further study 
is necessary to explore the direct relationship between muscle 
carnosine concentration and vitamin B6 status in an interven-
tional design, since this cross-sectional study cannot exclude 
confounding variables.
In the rat study, it is noteworthy that the concentration of 
β-alanine, a precursor of carnosine, in gastrocnemius muscles 
was markedly elevated by supplemental vitamin B6. Likewise, 
we consistently found a strong correlation between β-alanine 
and carnosine concentrations in this muscle. It remains to be 
determined which PLP-dependent enzymes are responsible for 
the changes in carnosine concentrations. β-Alanine is the rate-
limiting precursor of carnosine (25). The most important source 
of β-alanine is uracil degradation, but the enzymes involved 
are not PLP dependent. Enzymes that might be responsible 
are PLP-dependent transaminases “β-alanine – 2-oxoglutarate 
transaminase” (ABAT) and/or “β-alanine – pyruvate transami-
nase” (AGXT2). Animal study suggested β-alanine as one of 
the metabolites resulted from the injection of spermidine or 
spermine, which are produced by PLP-dependent ornithine 
decarboxylase from ornithine (26, 27). Interestingly, our study 
indicated significant inverse correlation between ornithine 
and β-alanine concentrations in gastrocnemius muscle, which 
shows more remarkable response of β-alanine to dietary vita-
min B6 compared to soleus muscle. This raises the possibility 
that the elevation in the level of β-alanine in the gastrocnemius 
muscle by dietary supplemental vitamin B6 is at least in part 
mediated by enhancing the conversion from ornithine to 
β-alanine in skeletal muscles. Further study is necessary to test 
this possibility.
In conclusion, the results of this study suggest that dietary 
vitamin B6 status is a determinant of carnosine concentration in 
laboratory rat skeletal muscles. The present study also suggests 
that vitamin B6 intake close to the range of regular daily intake 
is able to affect carnosine concentration in skeletal muscles. 
The link observed between plasma PLP and muscle carnosine 
in human subjects suggest a similar phenomenon likely exist in 
human. As histidine-containing dipeptides are critical for muscle 
function, this is a novel mechanism why adequate vitamin B6 
status is essential to safeguard optimal muscle contractility and 
exercise performance.
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